Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies

Journal of Immunology

Volumn 161, Issue 7, 1998, Pages 3557-3568

  Mukherjee, Jean ^a,c   Kozel, Thomas R ^b   Casadevaii, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MANNAN; MONOCLONAL ANTIBODY; OPSONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CRYPTOCOCCUS NEOFORMANS; FUNGICIDAL ACTIVITY; GENETIC ANALYSIS; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

EID: 0032193772     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Diamond, R. D. 1995. Cryptococcus neoformans. In Principles and Practice of Infectious Diseases, 4th Ed. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, p. 2331.
2. Bhattacharjee, A. K., J. E. Bennett, and C. P. J. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619.
3. Gordon, M. A., and D. K. Vedder. 1966. Serologic tests in diagnosis and prognosis of cryptococcosis. J. Am. Med. Assoc. 197:961.
4. Ito, T., M. J. Ueda, T. S. Okada, and S. Ohnishi. 1981. Phagocytosis by macrophages. II. The dissociation of the attachment and ingestion steps. J. Cell Sci. 51:189.
5. Mitchell, T. G., and J. M. Small. 1989. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect. Immun. 57:3751.
6. Dong, Z. M., and J. Murphy. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63:770.
7. Murphy, J. W., and G. C. Cozad. 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5:896.
8. Kozel, T. R., W. F. Gulley, and J. Cazin, Jr. 1977. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect. Immun. 18:701.
9. Sundstrom, J. B., and R. Chemiak. 1993. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A. Infect. Immun. 61:1340.
10. Currie, B. P., and A. Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:10129.
11. Casadevall, A., E. D. Spitzer, D. Webb, and M. G. Rinaldi. 1993. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob. Agents Chemother. 37:1383.
12. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595.
13. Chen, F., B. P. Currie, L. Chen, S. G. Spitzer, E. D. Spitzer, and A. Casadevall. 1995. Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1. J. Clin. Microbiol. 33:2818.
14. Mukherjee, J., M. Feldmesser, M. D. Scharff, and A. Casadevall. 1995. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy. Antimicrob. Agents Chemother. 39:1398.